Track topics on Twitter Track topics that are important to you
OncoCell MDx, a privately held immunogenomics company with a patented liquid biopsy platform, today announced it has changed its name to Immunis.AI. The name was chosen to better reflect the power an...
Brain centers possessing a suite of neuroanatomical characters that define mushroom bodies of dicondylic insects have been identified in mantis shrimps, which are basal malacostracan crustaceans. Rece...
Immunis.AI is a privately held immunogenomics company with a patented liquid biopsy platform that offers unique insights into disease biology, for a truly individualized assessment. Our Intelligentia...
We have published hundreds of Immunis.AI news stories on BioPortfolio along with dozens of Immunis.AI Clinical Trials and PubMed Articles about Immunis.AI for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Immunis.AI Companies in our database. You can also find out about relevant Immunis.AI Drugs and Medications on this site too.
The process of gene expression is used by eukaryotes, prokaryotes, and viruses to generate the macromolecular machinery for life. Steps in the gene expression process may be modulated, including the transcription, RNA splicing, translation, and post-tran...